Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syeda Maryam Azeem

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Molecular Graphics & Modelling|November 21, 2017
Structure-based methods to predict mutational resistance to diarylpyrimidine non-nucleoside reverse transcriptase inhibitorsSyeda Maryam Azeem, Alecia N Muwonge, Nehaben Thakkar, et al.
Frontiers in Oncology|May 20, 2025
Repurposing riluzole as an anti-osteosarcoma agentOkkeun Jung, Vinagolu K Rajasekhar, Syeda Maryam Azeem, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Riluzole as a Dual-Targeted Radiosensitizer for Osteosarcoma: Targeting Tumor Cells and Angiogenic Vasculature to Enhance Single High Dose Radiotherapy EfficacyPooja Prakash Rao, Charis Herbert, Syeda Maryam Azeem, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
EGR1 Mediates Riluzole-Induced Apoptosis in Osteosarcoma via the Yap/p73-Bax Signaling AxisSyeda Maryam Azeem, Shraddha ChandThakuri, Pooja Prakash Rao, et al.
Elife|March 7, 2023
Room-temperature crystallography reveals altered binding of small-molecule fragments to PTP1BTamar Skaist Mehlman, Justin T Biel, Syeda Maryam Azeem, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Molecular Graphics & Modelling|November 21, 2017
Structure-based methods to predict mutational resistance to diarylpyrimidine non-nucleoside reverse transcriptase inhibitorsSyeda Maryam Azeem, Alecia N Muwonge, Nehaben Thakkar, et al.
Frontiers in Oncology|May 20, 2025
Repurposing riluzole as an anti-osteosarcoma agentOkkeun Jung, Vinagolu K Rajasekhar, Syeda Maryam Azeem, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Riluzole as a Dual-Targeted Radiosensitizer for Osteosarcoma: Targeting Tumor Cells and Angiogenic Vasculature to Enhance Single High Dose Radiotherapy EfficacyPooja Prakash Rao, Charis Herbert, Syeda Maryam Azeem, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
EGR1 Mediates Riluzole-Induced Apoptosis in Osteosarcoma via the Yap/p73-Bax Signaling AxisSyeda Maryam Azeem, Shraddha ChandThakuri, Pooja Prakash Rao, et al.
Elife|March 7, 2023
Room-temperature crystallography reveals altered binding of small-molecule fragments to PTP1BTamar Skaist Mehlman, Justin T Biel, Syeda Maryam Azeem, et al.
Pageof 1